Business
Evolus Reaches 1 Million Redemptions in its Evolus Rewards™ Patient Loyalty Program
NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of
About this update from Evolus, Inc. Common Stock
[{"type":"text","content":" NEWPORT BEACH, Calif.--(BUSINESS WIRE)--\nEvolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, announced it recently completed the one-millionth Jeuveau® redemption through its Evolus Rewards™ patient loyalty program.\n\n\n“We designed Evolus Rewards™ as the first text-based loyalty program in the aesthetic space to create a connection with the millennial patient population,” said David Moatazedi, President and CEO. “In our first few years since introducing Evolus Rewards™, we have now achieved over one million transactions and are on track to reach all-time highs in both new and existing patients in the second quarter. Importantly, 96% percent of patients enrolled in Evolus Rewards™ return to their first practice for subsequent treatments, ensuring a long-term injector-patient relationship.”\n\n\nLaunched in 2020 soon after Jeuveau® was FDA approved in 2019, Evolus Rewards™ offers enrolled patients $40 off Jeuveau® treatments every 90 days at a participating provider’s practice. In addition to savings every 90 days, Evolus Rewards™ also offers patients a fun, frictionless experience delivered via text message for ease and convenience when checking in for an appointment. With no passwords to remember or credits to track, both patients and practices can effortlessly participate in the program.\n\n\nThe Evolus Rewards™ program also delivers on the Evolus mission of partnering with its customers to help grow their practices while bringing in the next generation of beauty consumers considering aesthetic injectables. On average, practices enrolled and engaged in Evolus Rewards™ grow significantly faster than non-participating practices.\n\n\nSince launch, 600,000 patients have enrolled in Evolus Rewards™ with the majority returning for a repeat treatment. Importantly, more than half of Evolus Rewards™ patients are millennials or younger, a number that represents the future of the aesthetics industry and a highly desirable demographic that providers want to attract as they continue to grow their businesses.\n\n\nAbout Evolus, Inc.\n\n\nEvolus (Nasdaq: EOLS) is a performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mi...